Cancer's trajectory, as viewed by targets at AACR, ASCO and ASH
What new targets presented at 2019's AACR, ASCO and ASH meetings say about the future of cancer R&D
Beyond the headliner presentations at 2019’s three major cancer conferences were over a hundred posters and presentations showcasing new or emerging targets. A look at the identity of those targets reveals the growing diversity of approaches researchers are taking to manipulate the tumor microenvironment.
Between them, the American Association for Cancer Research (AACR),